XML 92 R79.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders’ Equity (Deficit) (Details) - USD ($)
1 Months Ended 12 Months Ended
Jan. 15, 2021
Aug. 31, 2021
Aug. 26, 2021
Aug. 20, 2020
Dec. 31, 2021
Dec. 31, 2020
Sep. 09, 2021
Jan. 01, 2016
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Purchase Of Aggregate Shares     3,703,704          
Offering price per shares (in Dollars per share)     $ 0.54          
Aggregate purchase price     1,851,852          
Common share percentage     50.00%          
Exercise price (in Dollars per share)     $ 0.65          
Warrant to purchase price     269,269          
Number Of common share in percentage     8.00%          
Offering price per share (in Dollars per share)     $ 0.675          
Offering price per share     125.00%          
Exercise price payable (in Dollars)     $ 1,719,921          
Trusts contributed aggregate shares of common stock       76,026        
Fair value of marketable securities (in Dollars)       $ 3,066,889        
Aggregate shares of common stock       24,522,727        
Common shares, issued         2,998,122 1,114,861    
Voting Right Percentage       51.00%        
Beneficial conversion feature (in Dollars)         $ 825,000      
Debt total (in Dollars)         117,857      
Sales of stock, shares   3,703,704            
Proceeds from sale (in Dollars)           $ 698,000    
Exercise price (in Dollars per share)   $ 0.65            
Aggregate grant date fair value of warrants issued (in Dollars)         $ 43,236    
Deemed dividend (in Dollars)           $ 328,179    
Issued common shares upon exercise           927,398    
Warrants shares exercised           1,185,715    
Issuance of common stock             20,000,000  
Fair value of options granted (in Dollars per share)         $ 0.25 $ 0.07    
Shares issued to employee         157,652 104,841    
Stock options exercised (in Dollars)         $ 16,450 $ 16,450    
Stock options exercised         145,500 145,500    
Unrecognized compensation cost (in Dollars)         $ 16,014      
Weighted-average period         1 year 4 months 24 days      
Fair value of grants per share. (in Dollars per share)         $ 0.21 $ 0.13    
Aggregate fair value (in Dollars)         $ 135,805 $ 121,616    
Equity compensation (in Dollars)         165,000      
Amortization assets (in Dollars)         13,750      
Employee Equity Incentive Plan [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Stock based compensation recognized for grants (in Dollars)         $ 128,279      
Weighted-average period         2 years 7 months 6 days      
Employee Stock Option [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Stock based compensation recognized for grants (in Dollars)         $ 98,335      
Consultant [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Recognized expenses (in Dollars)         $ 495,246 $ 206,483    
Three Separate Private Placement [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Sales of stock, shares         13,161,943      
Proceeds from sale (in Dollars)         $ 4,328,725      
Private Placement [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Sales of stock, shares           7,022,867    
Series B Preferred Stock [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Shares authorized       2,750,000 20,000,000 20,000,000    
Common shares, issued       100        
Common Stock [Member] | Investment Agreement [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Common shares, issued         3,006,098 5,797,348    
Net proceeds (in Dollars)         $ 900,636 $ 489,286    
Minimum [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Exercise price (in Dollars per share) $ 0.223              
Stock option exercise price (in Dollars per share)         $ 0.1      
Maximum [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Stock option exercise price (in Dollars per share)           $ 0.252    
Employee Equity Incentive Plan [Member] | Common Stock [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Common shares, issued               15,503,680
Warrant One [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Warrants to purchase shares of common stock           0.27    
Warrant One [Member] | Three Separate Private Placement [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Warrants to purchase shares of common stock         6,581,527 3,511,444    
Exercise price (in Dollars per share)         $ 1.05 $ 0.16    
Three-year warrants [Member] | Three Separate Private Placement [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Exercise price (in Dollars per share)         $ 0.27      
Warrant [Member]                
Shareholders’ Equity (Deficit) (Details) [Line Items]                
Issued warrants         22,421,026 3,582,873    
Aggregate grant date fair value of warrants issued (in Dollars)         $ 5,823,476 $ 231,800    
Issued common shares upon exercise         333,750      
Warrants shares exercised         3,065,278      
Exercise price (in Dollars per share)         $ 0.09 $ 0.15    
Cashless exercise           9,047,332    
Warrant shares exercised           10,571,742    
Litigation and other disputes amounts (in Dollars)         $ 614,221